Texas Instruments stock holds firm at Equalweight despite capex shift

Published 21/08/2024, 13:48
© Reuters.

On Wednesday, Barclays maintained its Equalweight rating on Texas Instruments (NASDAQ:TXN), with a steady price target of $210.00. The company's recent communication indicated a more adaptable approach to its multi-year capital expenditure (capex) ramp-up, a move that is expected to be well-received by the market.

Although Texas Instruments has projected a low-end revenue range for calendar year 2026 that suggests a low teens compound annual growth rate (CAGR) and the possibility of two consecutive years of double-digit revenue growth—a scenario that has only occurred once before during the pandemic-induced chip shortages—this forecast may cause some unease among investors regarding the timing of the recovery.

The semiconductor manufacturer engaged more openly than usual during its recent call, addressing numerous inquiries that it typically avoids. This level of engagement underscored the company's thorough consideration of various factors, including market conditions in China and pricing strategies.

Most notably, Texas Instruments provided a soft guidance, suggesting a return to low to mid-60s percentage profitability by calendar year 2026, an improvement compared to current market expectations.

Barclays acknowledges that Texas Instruments' moderation in capex could be a positive step. However, there are reservations about the achievability of the company's top-line growth projections. While the tone towards the stock is more constructive, Barclays sees limited potential for an increase in its value at the current market price.

Texas Instruments' recent discussions have clarified their strategic considerations, particularly how they intend to navigate capex and address market conditions in the coming years. The company's openness in discussing its future has provided investors with a clearer picture of its financial trajectory and operational strategy.

In other recent news, Texas Instruments has experienced significant developments in its financial trajectory and strategic investments. Goldman Sachs has raised Texas Instruments' price target to $189, while maintaining a Sell rating. UBS has reaffirmed a Buy rating on the company's stock and Citi upgraded Texas Instruments from Neutral to Buy, following an improved margin outlook. Deutsche Bank has also adjusted its price target for Texas Instruments to $200, maintaining a Hold rating.

Texas Instruments recently reduced its capital expenditure forecast for 2026 and announced plans to construct three new facilities and expand its 300mm production capacity, securing up to $1.6 billion in funding from the U.S. CHIPS and Science Act for these constructions. The company's projected free cash flow per share by 2026 is estimated to range from $8 to $12, surpassing the analyst consensus estimate of $6.91.

InvestingPro Insights

Texas Instruments (NASDAQ:TXN) has recently caught the attention of Barclays, and with the latest insights from InvestingPro, investors can glean additional context for this assessment. Notably, Texas Instruments stands as a prominent player in the Semiconductors & Semiconductor Equipment industry, a detail that aligns with their strategic capex discussions and growth projections mentioned by Barclays.

InvestingPro Data highlights a current market capitalization of $184.93 billion and a P/E ratio of 34.9, signaling that the company is trading at a high earnings multiple. This is corroborated by an adjusted P/E ratio for the last twelve months as of Q2 2024 sitting at 35.74. Despite a revenue decline of 14.5% over the last twelve months as of Q2 2024, Texas Instruments maintains a strong gross profit margin of 59.36%, indicating effective cost management relative to its sales.

In terms of shareholder returns, Texas Instruments has a remarkable track record, having raised its dividend for 20 consecutive years. This commitment to returning value to shareholders is further underlined by a dividend growth of 4.84% over the last twelve months as of Q2 2024. Additionally, the company's liquid assets exceed its short-term obligations, which is a reassuring sign of financial stability.

InvestingPro Tips suggest that while analysts anticipate a sales decline in the current year, they have revised their earnings upwards for the upcoming period, reflecting optimism about the company's profitability. Moreover, Texas Instruments is trading near its 52-week high, with a price percentage of 96.06% of the peak, which could indicate market confidence in the stock.

For readers interested in a deeper dive into Texas Instruments' performance and future outlook, InvestingPro offers additional tips. Currently, there are 17 more InvestingPro Tips available for Texas Instruments at https://www.investing.com/pro/TXN, providing a comprehensive analysis for informed investment decisions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.